This Week in Virology

TWiV 769: MIS-C and leaky gut

06.17.2021 - By Vincent RacanielloPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

On this episode of TWiV, Novavax COVID-19 vaccine demonstrates 90% overall efficacy, preventing an antigenically disruptive change during growth of influenza virus vaccine in chicken eggs, and MIS-C is driven by loss of the gut mucosal barrier. Hosts: Vincent Racaniello, Kathy Spindler, and Brianne Barker Click arrow to play Download TWiV 769 (68 MB .mp3, 114 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ASV Vaccine Town Hall 2:05 Novavax vaccine efficacy reported (Novavax) H3N2 glycosylation in eggs (TWiV 480) Preventing antigenically disruptive HA change in eggs (Cell Host Micr) MIS-C due to leaky gut (J Clin Invest) Letters read on TWiV 769 Timestamps by Jolene. Thanks! Weekly Picks Brianne – Pandemics for Babies, Germ Theory for Babies, and Vaccines for Babies Kathy – Playing with Time Vincent – A Top Virologist in China, at Center of a Pandemic Storm, Speaks Out Intro music is by Ronald Jenkees Send your virology questions and comments to [email protected]

More episodes from This Week in Virology